Recilisib 是辐射防护剂，能够提高细胞中Akt和PI3K的活性。

Recilisib is a radioprotectant,can activate AKT, PI3K activities in cells.

Recilisib Sodium increases PI3K activity in HFL-1 cells and murine bone marrow cells in response to radiation exposure. Recilisib Sodium treatment in combination with radiation alters the MAPK signaling pathway.

the rate of recovery and differentiation of primitive bone marrow myeloid progenitor cells in mice significantly increased by Recilisib Sodium. Recilisib Sodium in combination with radiation reduces CFU numbers in mice, but the Recilisib Sodium-treated mice consistently retain a capability to form differentiated colonies. Recilisib Sodium treated mice have a progenitor cell population that is never completely depleted by radiation exposure.

334969-03-8

C16H13ClO4S

336.79

ON 01210;Ex-RAD;RECILISIB 钠盐

DMSO:35.71 mg/mL (106.03 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years